DCF — NASSAU UNIVERSITY MEDICAL CENTER
Enterprise Value: $-381.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-381.1M
Enterprise Value
$-127.5M
PV of Cash Flows
$-253.6M
PV of Terminal Value
$-408.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $443.9M | $-20.0M | -5.0% | $-38.8M | $-35.2M |
| Year 2 | $457.2M | $-16.0M | -4.0% | $-35.4M | $-29.2M |
| Year 3 | $470.9M | $-11.8M | -3.0% | $-31.7M | $-23.8M |
| Year 4 | $485.0M | $-9.7M | -2.0% | $-30.2M | $-20.6M |
| Year 5 | $499.6M | $-8.7M | -2.0% | $-29.9M | $-18.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-381.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$430.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000046409209
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5